1. Home
  2. ATYR vs SNFCA Comparison

ATYR vs SNFCA Comparison

Compare ATYR & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.74

Market Cap

79.2M

Sector

Health Care

ML Signal

HOLD

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

HOLD

Current Price

$9.30

Market Cap

234.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATYR
SNFCA
Founded
2005
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
79.2M
234.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ATYR
SNFCA
Price
$0.74
$9.30
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
2.2M
41.1K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.74
Revenue
$190,000.00
$340,876,482.00
Revenue This Year
N/A
N/A
Revenue Next Year
$18,728.88
N/A
P/E Ratio
N/A
$12.50
Revenue Growth
N/A
3.25
52 Week Low
$0.64
$7.32
52 Week High
$7.29
$12.83

Technical Indicators

Market Signals
Indicator
ATYR
SNFCA
Relative Strength Index (RSI) 41.71 64.66
Support Level $0.70 $8.84
Resistance Level $0.83 $9.46
Average True Range (ATR) 0.05 0.31
MACD 0.01 0.05
Stochastic Oscillator 26.75 80.61

Price Performance

Historical Comparison
ATYR
SNFCA

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

Share on Social Networks: